Ethical AI - can wearable sensors with embedded AI detect Parkinson’s Disease symptoms?

These scholarships will cover full-time PhD tuition fees for three years (subject to satisfactory academic performance) and will provide a £900 per annum research training support grant (RTSG) to help support the PhD researcher.

Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a full-time basis for more than one year (or part-time equivalent) are NOT eligible to apply for an award.

Please note: you will automatically be entered into the competition for the Full Award, unless you state otherwise in your application.

The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £19,000 (tbc) per annum for three years (subject to satisfactory academic performance).

This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

[1]G. Deuschl et al., “The burden of neurological diseases in Europe: an analysis for the Global Burden of  Disease Study 2017.,” Lancet. Public Heal., vol. 5, no. 10, pp. e551–e567, Oct. 2020, doi: 10.1016/S2468-2667(20)30190-0.

[2]        Y. Tizabi, B. Getachew, A. Csoka, and K. Manaye, “Gender differences in prominent neurodegenerative diseases.,” vol. 11, pp. 5–19, Feb. 2019.

[3]        A. J. Lees, J. Hardy, and T. Revesz, “Parkinson’s disease,” Lancet, vol. 373, no. 9680, pp. 2055–2066, 2009, doi: https://doi.org/10.1016/S0140-6736(09)60492-X.

[4]        E. Commission and Eurostat, Ageing Europe : looking at the lives of older people in the EU : 2020 edition. Publications Office, 2020.

[5]        M. A. Rocca et al., “Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.,” Lancet. Neurol., vol. 14, no. 3, pp. 302–317, Mar. 2015, doi: 10.1016/S1474-4422(14)70250-9.

[6]        A. Kouli, K. M. Torsney, and W.-L. Kuan, “Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis Parkinson’s Disease: Etiology, Neuropathology, and PathogenesisKouli, A. (2018). Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis. 3–26.,” Park. Dis. Pathog. Clin. Asp., pp. 3–26, 2018.

[7]        T. Schirinzi, D. Landi, and C. Liguori, “COVID-19: dealing with a potential risk factor for chronic neurological disorders,” J. Neurol., vol. 268, no. 4, pp. 1171–1178, 2021, doi: 10.1007/s00415-020-10131-y.

[8]        R. A. Hauser et al., “A Home Diary to Assess Functional Status in Patients with Parkinson’s Disease with Motor Fluctuations and Dyskinesia,” Clin. Neuropharmacol., vol. 23, no. 2, 2000, [Online]. Available: https://journals.lww.com/clinicalneuropharm/Fulltext/2000/03000/A_Home_Diary_to_Assess Functional_Status_in.3.aspx.

[9]        J. Reimer, M. Grabowski, O. Lindvall, and P. Hagell, “Use and interpretation of on/off diaries in Parkinson{\textquoteright}s disease,” J. Neurol. Neurosurg. \& Psychiatry, vol. 75, no. 3, pp. 396–400, 2004, doi: 10.1136/jnnp.2003.022780.

[10]      M. Stacy et al., “Identification of motor and nonmotor wearing-off in Parkinson’s disease: Comparison of a patient questionnaire versus a clinician assessment,” Mov. Disord., vol. 20, no. 6, pp. 726–733, 2005, doi: https://doi.org/10.1002/mds.20383.

[11]      M. K. Erb et al., “mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease,” npj Digit. Med., vol. 3, no. 1, p. 6, 2020, doi: 10.1038/s41746-019-0214-x.